A MULTICENTER, OPEN LABEL STUDY TO INVESTIGATE THE FEASIBILITY AND EFFICACY OF A SMOKING CESSATION PROGRAM WITH VARENICLINE IN PATIENTS UNDERGOING ELECTIVE SURGERY

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-010173-20

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

- Assess the feasibility of conducting a multicentre prospective trial involving smoking cessation treatment, pre-planned and scheduled surgery and collection of data on surgical site infections and other post-operative complications. - Generate data on rates of surgical site infections and other post-operative complications in patients undergoing elective orthopaedic, plastic, general and vascular surgery. - Assess the practicality and utility of three separate instruments in recording data on surgical site infection and in assessing and grading surgical site infections and of a further instrument in grading other post-operative complications. - Assess the efficacy of Varenicline and smoking cessation advice to enable cessation of smoking for the 7 day period preceding hospital admission in patients undergoing elective surgery


Critère d'inclusion

  • Smoking cessation in patients scheduled for elective surgery